Infectious Diseases
News from the FDA/CDC
CDC warns of early uptick in respiratory disease
As influenza viruses, respiratory syncytial virus, SARS-CoV-2, and rhinovirus/enterovirus simultaneously circulate, the agency cautioned that this...
Latest News
COVID bivalent booster better vs. recent Omicron subvariants: Pfizer
An ongoing phase 2 trail shows the vaccine offered the strongest protection in people older than 55 years.
News from the FDA/CDC
FDA expands tenofovir alafenamide (Vemlidy) use to adolescents with chronic HBV
The study met its primary endpoint of percentage of patients with HBV DNA levels less than 20 IU/mL at 24 weeks of therapy.
Latest News
RSV vaccine given during pregnancy protects newborns: Pfizer
The company reported the vaccine prevented severe illness particularly well during the first 90 days of life, with measurable protection ......
Latest News
Shortage reported of antibiotic commonly used for children
The American Society of Health-System Pharmacists issued an alert for the amoxicillin shortage last week via its real time drug shortage database...
News from the FDA/CDC
Mid-October flulike illness cases higher than past 5 years
The 2022-2023 season is already “gathering speed … about a month early,” one expert said.
News from the FDA/CDC
Children and COVID: Weekly cases can’t sustain downward trend
Hospitalizations and emergency department visits may be on the rise again.
Feature
Is it flu, RSV, or COVID? Experts fear the ‘tripledemic’
Predicting exactly when cases will peak is difficult.
News from the FDA/CDC
Children and COVID: Weekly cases fall to lowest level in over a year
Reported new cases have dropped by almost 75% since the beginning of September.
Latest News
Florida sees spike in deadly bacterial infections after Hurricane Ian
Vibrio vulnificus bacteria is found in warm, brackish seawater, according to the Florida Department of Health.
Conference Coverage
25 years of chickenpox vaccine: 91 million cases prevented
“The declines in deaths, let alone hospitalizations, were jaw-dropping. I hadn’t really seen a synthesis of the impact of one and two doses.”